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Abstract
Background: To analyze the epidemiological characteristics and pathogenic molecular characteristics of an hand,
foot, and mouth disease (HFMD) outbreak caused by enterovirus 71 in Linyi City, Shandong Province, China during
November 30 to December 28, 2010.
Methods: One hundred and seventy three stool specimens and 40 throat samples were collected from 173
hospitalized cases. Epidemiologic and clinical investigations, laboratory testing, and genetic analyses were
performed to identify the causal pathogen of the outbreak.
Results: Among the 173 cases reported in December 2010, the male–female ratio was 1.88: 1; 23 cases (13.3%)
were severe. The majority of patients were children aged < 5 years (95.4%). Some patients developed respiratory
symptoms including runny nose (38.2%), cough (20.2%), and sore throat (14.5%). One hundred and thirty eight
EV71 positive cases were identified based on real time reverse-transcription PCR detection and 107 isolates were
sequenced with the VP1 region. Phylogenetic analysis of full-length VP1 sequences of 107 Linyi EV71 isolates
showed that they belonged to the C4a cluster of the C4 subgenotype and were divided into 3 lineages (Lineage I,
II and III). The two amino acid substitutions (Gly and Gln for Glu) at position 145 within the VP1 region are more
likely to appear in EV71 isolates from severe cases (52.2%) than those recovered from mild cases (8.3%).
Conclusion: This outbreak of HMFD was caused by EV71 in an atypical winter. EV71 strains associated with this
outbreak represented three separate chains of transmission. Substitution at amino acid position 145 of the VP1
region of EV71 might be an important virulence marker for severe cases. These findings suggest that continued
surveillance for EV71 variants has the potential to greatly impact HFMD prevention and control.
Keywords: Hand, Foot, and mouth disease, HFMD, Enterovirus 71, Phylogenetic analysis, Subgenotype C4
Background
Hand, foot, and mouth disease (HFMD), primarily a dis-
ease of young children, is caused by a virus belonging to
the group enteroviruses. EV71 is known to be a causa-
tive agent of HFMD, herpangina, aseptic meningitis, par-
alysis, and meningoencephalitis [1]. HFMD usually
presents with symptoms including fever and a character-
istic rash associated with the limbs, mouth and skin. In
severe disease such as caused by EV71, however, the
patients may develop nervous system diseases such as
aseptic meningitis, encephalitis, brainstem encephalitis,
encephalomyelitis, and poliomyelitis-like syndrome as
well as neurogenic pulmonary edema and myocarditis,
resulting in high morbidity and mortality [2].
EV71 was first isolated in the United States (California)
in 1969 and by the mid-1970s, EV71 outbreaks, character-
ized by central nervous system complications occurred in
succession in Bulgaria and Hungary [3]. In the late 1990s,
EV71 emerged in East Asia. In 1997, 2628 cases in
Malaysia were reported, with 34 deaths [4]. One year later,
an estimated 1.5 million cases occurred in Taiwan; 405
cases developed severe neuropathic complications with 78
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deaths [5]. In 1999, an EV71 pandemic occurred in Perth,
Australia; 6000 cases were reported in 6 months; 29 cases
developed severe disease [6]. Subsequently, numerous out-
breaks have been documented in eastern and southeastern
Asia, including Singapore [7], South Korea [8], Malaysia
[9], Japan [10], Vietnam [11] and mainland China. In 2008,
a large scale outbreak of HFMD occurred in Anhui Prov-
ince, China; 3321 cases were reported with 22 deaths [12].
HFMD outbreaks associated with EV71 exhibit a sig-
nificant seasonal pattern with a peak in summer and
low incidence in winter [13,14], however the number
of HFMD cases increase significantly with increasing
temperature and relative humidity [13,15]. In this study,
we describe an atypical winter outbreak of HFMD from
November 30 to December 28, 2010, in Linyi City, Shan-
dong Province, China, during which 173 cases were ad-
mitted to the Linyi People's Hospital. In this study, we
analyzed the epidemiological characteristics of this out-
break and the molecular epidemiology of EV71, with an
attempt to provide scientific evidence for the prevention
and control of HFMD.
Methods
Case information and clinical samples
One hundred and seventy three patients admitted to
Linyi City People's Hospital were enrolled in the study.
Case information was obtained from the hospital infor-
mation system including age, gender, onset date, place of
onset and clinical information. All 173 cases were diag-
nosed according to a standardized clinical case definition
of HMFD [16]. HFMD was defined as fever, accompan-
ied by herpangina and rashes on the hands and feet, with
or without buttock involvement. Severe HFMD patients
presented with obvious symptoms of nervous system in-
volvement and severe complication, such as myoclonus,
encephalitis, acute flaccid paralysis, pulmonary edema,
or heart failure. To confirm the diagnosis of HMFD, 213
specimens (173 stool and 40 throat swabs) were col-
lected for enterovirus detection and molecular typing.
Throat swabs were immediately immersed into sterile
tubes containing viral transport medium (VTM). The
study protocol was approved by the Medical Ethics
Committee of Academy of Military Medical Sciences.
Virus isolation
Approximately 0.5 g of a fecal sample was put into a
1.5 ml centrifuge tube with a glass bead. After addition
of 1 ml of phosphate buffer, the solution was vortexed
for 1 min and centrifuged at 4000 rpm for 10 min. Fecal
supernatants and the VTM from tubes containing throat
samples were filtered through a 0.22 or 0.45 μm syringe
filter (Pall, Ann Arbor, MI, USA). Filtrates were cultured
with human rhabdomyosarcoma cells (RD cells) at 37°C
and 5% CO2 for 7 days. Cells were observed daily for
cytopathic effects (CPE). Each specimen was passaged
blindly at least 3 times. Cells demonstrating an observed
CPE were repeatedly frozen and thawed 3 times to allow
for RNA extraction and identification using molecular
biology approaches, and then cell cultures and RNAs
were stored at −80°C. If no specific CPE was observed
cell culture was interpreted as negative.
Nucleic acid extraction and molecular typing
Viral RNA was extracted from clinical specimens and
viral cultures using a QIAamp Viral RNA Mini Kit
(Qiagen, Germany) according to the manufacturer's in-
structions. All RNA samples were examined by real time
reverse-transcription PCR (rt RT-PCR) using a set of
Pan-EV (EV universal primer) probe and primers; posi-
tive samples were tested by rt RT-PCR for EV71 and
CA16 using specific primers and probes [17]. Rt RT-
PCR was performed using AgPath-ID™ One-Step RT-
PCR reagents (Applied Biosystems, Foster, CA, USA).
Total DNA was extracted from 40 throat specimens
using QIAamp DNA Blood Mini Kit (Qiagen, Germany).
Commercial available multiplex PCR assays (Seeplex®
RV12 ACE, Korea) was used for testing respiratory vi-
ruses of 40 throat specimens, including human adeno-
virus, coronaviruses, parainfluenza viruses, influenza A
virus, influenza B virus, respiratory syncytial virus A and
B, and bocavirus. Amplification was performed using an
IQ™5 quantitative real-time PCR system (BioRad,
Hercules, CA, USA).
Full-length VP1 sequences from EV71 isolates were
amplified with the primers EV71-VP1-F, GGKGCRCC
CAAYACWGCYT and EV71-VP1-R, CCVCCRCAAT
CHCCWGGYT, resulting in a 981-bp amplicon. PCR
was performed using a GeneAmp 9700 Thermal Cycler
(Applied Biosystems). PCR products were detected by
agarose gel electrophoresis, and products were purified
and sequenced with an ABI PRISM 3730 Genetic
Analyzer (Applied Biosystems). An online Blast Search
Tool (http://blast.ncbi.nlm.nih.gov/Blast.cgi) was used to
compare the sequences and determine the types. The
constituent ratio of amino acid variation between severe
cases and mild cases strains was compared with Chi-
square test by SAS software (version 9.0; SAS Institute).
Phylogenetic analysis
Multiple sequence alignments were performed by using
the MEGA software version 5.2 and the Clustal W pro-
gram to determine nucleotide and amino acid seq-
uence similarities. Phylogenetic trees were constructed in
MEGA using the neighbor-joining (NJ) cluster algorithm
with evolutionary distances estimated using the Kimura
2-parameter model; bootstrapping was performed using
1,000 pseudo-replicates [18].
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Nucleotide sequence accession numbers
The full sequences of VP1 from this study are deposi-
ted in GenBank with the following accession numbers:
KF853482-KF853549, KJ185132-KJ185170.
Results
Epidemiological analysis and clinical symptoms
A total of 173 HFMD cases (including 23 with severe pres-
entation) were diagnosed and treated in Linyi People's Hos-
pital from November 30 to December 28, 2010 (Figure 1).
The majority of patients were children aged < 5 years
(95.4%) with the male–female ratio of 1.88:1. Cases pre-
sented from 9 counties or districts; although the incidence
was greatest in Lanshan District (35.8%) and Fei County
(31.2%).
All cases had fever and the characteristic rashes associ-
ated with the limbs, mouth and skin. Severe cases were
associated with meningitis (n = 15) or more severe neuro-
logical complications (meningoencephalitis, n = 3; neuro-
genic pulmonary edema, n = 5); no deaths were observed.
Although some patients developed respiratory symptoms
including runny nose (38.2%), cough (20.2%), and sore
throat (14.5%), testing with multiplex PCR assays of a sub-
set of throat samples (n = 40) for respiratory viruses in-
cluding human adenovirus, coronaviruses, parainfluenza
viruses, influenza A virus, influenza B virus, respiratory
syncytial virus A and B, and bocavirus were all negative. A
small number of patients also reported nausea, or experi-
enced vomiting, diarrhea, and other gastrointestinal symp-
toms. Most cases were accompanied by characteristic
neurological symptoms including drowsiness and convul-
sions (Table 1).
Laboratory identification
All RNA samples were examined by rt RT-PCR for the
presence of any detectable enterovirus (Pan EV screen)
and then specifically for EV71 and CA16. Among the
Figure 1 Epidemic curve of the HMFD outbreak in Linyi City, Shandong Province, China, 2010.
Table 1 Summary of clinical characteristics associated
with an outbreak of HMFD due to EV71 in Linyi City,
Shandong Province, China in 2010
























Neurogenic pulmonary edema 5 (2.9)
Severe cases 23 (13.3)
Mild cases 140 (86.7)
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213 specimens, an amplicon was evident in 148 of the
samples, taken from 138 cases, using the Pan-EV
primers and probes. Using primers and probes specific
for EV71, the 148 Pan EV-positive specimens were also
positive; stool specimens were positive from 138 cases,
and 10 cases who had a throat swab and fecal sample
both tested positive. Primers and probes specific for
CA16 were negative in all the samples. Viral samples
from the ten patients with two positive samples were in-
distinguishable. In total, 107/213 (50.2%) samples from
107 individual cases were culture-positive for EV71;
identification was confirmed by rt RT-PCR amplification
and sequencing of VP1 regions; 23 isolates (10.8%) were
recovered from severe cases and 84 isolates (39.4%) from
mild cases.
EV71 phylogenetic analysis
In order to analyze molecular epidemiological character-
istics of the EV71 isolates in this study, 107 EV71
isolates were selected from this outbreak, and VP1 se-
quences were compared to those from 10 EV71 isolates
circulating in China and 19 additional EV71 strains (A,
B1- B5, and C1 - C5) isolated from children living in
other countries (Figure 2). Sequence alignments showed
the 107 Linyi EV71 VP1 sequences shared 96.2-100%
nucleotide identity. Sequences of the VP1 region of the
Linyi EV71 isolates were closely related to the predom-
inant EV71 isolates from China, and all isolates belonged
to subgenotype C4. Subgenotype C4 can be divided into
two groups (C4a and C4b) [19]. According to the phylo-
genetic analysis (Figures 2 and 3), all of the Linyi EV71
isolates belong to C4a; isolates were further divided into
three lineages (lineage I, II, and III) with mean intra-
lineage p-distances of 0.007, 0.017 and 0.016, respect-
ively. The majority of the outbreak isolates (97/107)
belonged to lineage I which contained all of the isolates
from the severe cases; these isolates were mainly found
in three districts or counties of Linyi City, Shandong
Province (Lanshan District, Fei County and Hedong Dis-
trict). Lineage II and lineage III had three and seven out-
break isolates, respectively. VP1 nucleic acid dissimilarity
among the three subgroups ranged from 2.2%- 3.3%; these
results suggest that the outbreak likely consisted of three
main transmission chains, with lineage I being the pre-
dominant contributor.
Amino acid sequence analysis
Comparison of the translated VP1 amino acid sequences
(297 aa) of the EV71 isolates used in this study indicated
that the isolates were 98.6% identical to one another;
variable amino acid residues were at positions 31, 43, 98,
145, 282, 262 and 293. Substitution at amino acid pos-
ition 145 of VP1 appeared to be significantly different
between severe cases and mild cases strains. Two amino
acids, Gly and Gln, were significantly more likely to ap-
pear in the VP1 of EV71 recovered from severe cases
Figure 2 Dendrogram showing the phylogenetic relationships of 107 EV71 isolates in this outbreak and other genotypes of EV71
isolates from GenBank based on VP1 sequence alignment, which was constructed using Mega software (version 5.2).
Liu et al. BMC Infectious Diseases 2014, 14:123 Page 4 of 8
http://www.biomedcentral.com/1471-2334/14/123
(12/23, 52.2%) than in mild cases (7/84, 8.3%; P < 0.001)
(Figure 4).
Discussion
HFMD epidemics in China mainly occur in the spring
and summer [20-22], when hot and humid weather is
conducive to the propagation and spread of the virus
[23]. However, the Linyi 2010 HFMD outbreak occurred
in December, which is relatively uncommon. According
to meteorological parameters provided by the Meteoro-
logical Bureau of Shandong Province, the mean tem-
perature of Linyi City during the winter of 2010 was
0.6°C higher than that in 2009. Flett et al. suggested that
atypical seasonality of HFMD outbreaks during winter
might be related to unusually mild temperatures [24].
Research in Hong Kong has also indicated that altered
disease etiology of HFMD might be explained by in-
creased winter temperatures [25]. It is reasonable to
speculate that the short-term changes in weather vari-
ables may affect the seasonality of HFMD. However, cold
weather increases the probability that populations will
gather in confined spaces such as houses and indoor
play areas; increasing the likelihood of unwanted expo-
sures. In addition, more upper respiratory tract infec-
tions occur during the winter, resulting in a decrease in
immune functions among pediatric patients, which
might contribute to increasing incidence of HFMD.
The epidemiology of EV71 in China since this virus
was first detected in 1998 has shown that only subgeno-
type C4 is in endemic circulation [19]. Phylogenetic ana-
lysis suggests that three EV71 variants contributed to
the 2010 Linyi outbreak and share strong similarities to
some EV71 viruses circulating previously in Shandong
Province. However, no obvious evidence revealed the
transmission relationship between strains from this out-
break and other provinces in China. Therefore, we
speculate that this uncommon winter outbreak did not
occur in isolation, but was related with local epidemic
occurring in the region during the spring and summer
of 2010. It is probable that the change of climatic pa-
rameters contributed to the occurrence of this atypical
seasonal outbreak but the extent of this contribution
needs to be further examined.
Subgenotype C4a is geographically broadly distributed
and genetically variable; it is estimated to undergo
4.97 × 10−3 substitutions per nucleotide per year, a rapid
rate of change [26]. Phylogenetic analysis shows that
subgenotype C4 should be re-designated as a novel
Figure 3 Phylogenetic tree of 107 EV71 isolates in this outbreak
and related C4a subgenotype strains. Accession numbers are given
in parentheses. ▲, isolates from severe cases. LY, isolates from
this study; SD, Shandong Province; ZJ, Zhejiang Province; BJ, Beijing City;
JS, Jiangsu Province; CQ, Chongqing City.
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genotype, D [27,28]. Thus, the three lineages may repre-
sent different EV71 transmission modes in this region;
this hypothesis should be clarified by further molecular
epidemiological studies.
Amino sequence analysis showed one primary variation
between viruses isolated from severe and mild cases of
HFMD, substitution of the amino acid residue at position
145. Several studies have revealed that this change in the
VP1 region of EV71 may play an important role in virulence.
Residue 145 is reported to be located in the DE loop which
contains neutralizing antigenic sites; this loop is located in
the canyon rim, a region involved in the receptor binding
for enterovirus and rhinovirus [29-32]. Selection pressure
analysis of many VP1 sequences of EV71 showed that amino
acid 145 was a positive selection site [33,34]. Mutation of
glutamine to glutamic acid on VP1 145 region cooperatively
promote viral binding and RNA accumulation of EV71, con-
tributing to viral infectivity in vitro and mouse lethality
in vivo [35]. Substitution of glycine to glutamic acid at the
same position might increase the efficiency of uncoating
upon specific binding of the virion to the receptor molecule
on the target cells in NOD/SCID mice and subsequently fa-
cilitate the infection of a mouse adapted EV71 strain [36].
Although it has been demonstrated that the amino acid sub-
stitution of Gly to Glu at position 145 of VP1 could increase
EV71 virulence in mice, Glu to Gly/Gln/Arg substitutions
may enhance virulence in humans [37]. Consistent with this
result, isolates from severe cases in our investigation were
significantly more likely to carry the Gly/Gln at amino acid
145 than those from mild cases. This substitution may influ-
ence the virus binding to antibody or receptor, thereby af-
fecting the virulence of the virus [37].
Conclusions
In conclusion, HFMD caused by EV71 has become a
global concern in recent years. In February 2008, HFMD
Figure 4 Amino acid sequence alignment of the full length VP1 region of the EV71 virus isolates in Linyi City, Shandong Province,
2010. Amino acid sequences were numbered according to the sequence of EV71_BrCr (Genbank accession number: ETU22521). Identical residues
are indicated as dots. Amino acids that differ from the consensus sequence are shaded.▲, isolates of severe cases.
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was officially categorized as a Class C infectious disease in
China. Further studies on the transmission patterns of
EV71 using approaches in molecular biology are therefore
warranted, and recognizing EV71 isolates with increased
virulence should be a priority for HFMD prevention and
control efforts. Moreover, monitoring the genetic variation
of EV71 may be useful in facilitating the development of
effective EV71 vaccine candidates on Chinese market and
evaluating their effects of prevention and control of the
EV71 infections.
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